NASDAQ: REGN $51 Billion Large-Cap. Nasdaq 100. S&P 500. Health Care Sector. Biotech & Pharma Industry. 5 Year Return 17%. 1 Year Return 7%. 2021 YTD Return 1%. Earnings in 22 days on Thu, May 6.
The 52 Week Low is $446.38 set on Wed, Mar 3, 2021.
The 52 Week High is $664.64 set on Mon, Jul 20, 2020.
The All-Time High is $664.64 set on Mon, Jul 20, 2020.
Earnings Per Share
Price To Earnings Ratio
Dividend Yield
Dividend Rate
Ex-Dividend Date
Dividend Payment Date
Dividend Frequency
Dividend History
Regeneron Pharmaceuticals trades on the NASDAQ. REGN's market cap is 50.7 Billion.
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products including: Eylea, approved for wet age-related macular degeneration and other eye diseases; Praluent for LDL cholesterol lowering; Dupixent in atopic dermatitis, asthma, and nasal polyposis; Libtayo in cutaneous squamous cell carcinoma; and Kevzara in rheumatoid arthritis. Regeneron is also developing monoclonal antibodies with Sanofi in immunology and cancer, and bispecific antibodies and antibody cocktails with other collaborators and independently.
Watch these videos to learn how Symbol Surfing can increase your trading and investing knowledge and results.
Mon, Apr 12, 2021
Sun, Apr 11, 2021
Thu, Apr 8, 2021
Thu, Apr 8, 2021
Sun, Apr 4, 2021
Fri, Apr 2, 2021
Thu, Apr 1, 2021
Tue, Mar 30, 2021
Sun, Mar 28, 2021
Sun, Mar 28, 2021
Sat, Mar 27, 2021
Fri, Mar 26, 2021
Fri, Mar 26, 2021
Wed, Mar 24, 2021
Mon, Mar 22, 2021
Sun, Mar 21, 2021
Fri, Mar 19, 2021
Fri, Mar 19, 2021
Thu, Mar 18, 2021
Thu, Mar 18, 2021
Wed, Mar 17, 2021
Wed, Mar 17, 2021
Tue, Mar 16, 2021
Tue, Mar 16, 2021
Mon, Mar 15, 2021
Mon, Mar 15, 2021
Sun, Mar 14, 2021
Fri, Mar 12, 2021
Thu, Mar 11, 2021
Thu, Mar 11, 2021
Thu, Mar 11, 2021
Wed, Mar 10, 2021
